Mochida Pharmaceutical Co. Ltd
Research Mochida Pharmaceutical Co. Ltd (MFY) on Bullrun: market cap EUR 606.67M, P/E 14.3, dividend yield 2.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMFY
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 606.67M
- P/E14.3
- Dividend yield2.5%
- Financial periodFY2026
- RevenueJPY 116.95B
- Revenue growth11.2%
- Net incomeJPY 7.90B
- Free cash flow-JPY 10.05B
- Gross margin48.1%
Valuation Snapshot
latest market cap is EUR 606.67M; P/E is 14.3; dividend yield is 2.5%.
Peer valuation comparison
Latest P/E is 14.33x versus a Healthcare sector median of 24.46x (41.4% below).
Latest dividend yield is 2.54% versus a Healthcare sector median of 2.11% (20.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 116.95B | JPY 7.90B | -JPY 10.05B | 48.1% | 222.96 | JPY 28.06B | JPY 10.00B | JPY 140.32B |
| FY2025 | JPY 105.16B | JPY 5.69B | JPY 7.19B | 51.1% | 160.36 | JPY 45.15B | n/a | JPY 130.69B |
| FY2024 | JPY 102.89B | JPY 4.55B | -JPY 9.78B | 50.6% | 126.8 | JPY 33.29B | n/a | JPY 127.97B |
| FY2023 | JPY 103.26B | JPY 6.65B | JPY 5.13B | 53.4% | 178.93 | JPY 47.01B | n/a | JPY 126.77B |
| FY2022 | JPY 110.18B | JPY 10.57B | JPY 4.36B | 54.1% | 277.39 | JPY 48.42B | n/a | JPY 128.64B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 606.67M | 14.3 | 2.7% | 0.46 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.46 EUR, yield 2.5%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.22 JPY |
| FY2025 | 0.43 JPY |
| FY2024 | 0.43 JPY |
| FY2023 | 0.43 JPY |
| FY2022 | 0.49 JPY |
About Mochida Pharmaceutical Co. Ltd
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mochida Pharmaceutical Co. Ltd's market cap?
Mochida Pharmaceutical Co. Ltd's market capitalization is EUR 606.67M.
What is Mochida Pharmaceutical Co. Ltd's P/E ratio?
Mochida Pharmaceutical Co. Ltd's price-to-earnings (P/E) ratio is 14.3.
Does Mochida Pharmaceutical Co. Ltd pay a dividend?
Mochida Pharmaceutical Co. Ltd has a dividend yield of 2.5%.
What does Mochida Pharmaceutical Co. Ltd do?
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with.